
CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma
Keywords: مهارکننده; Multiple myeloma; Delanzomib; Lenalidomide; Dexamethasone; In vivo; Proteasome; Inhibitors;